Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
C.GRCM | 5 hours ago VANCOUVER, BC, June 7, 2024 – Geologica Resource Corp. (CSE:GRCM, FSE:862 ) (“Geologica” or the “Company”) is pleased to announce the closing of its previously announced financing and property acquisition. The Company intends to issue 4,301,450 Units at $0.035 per unit for total proceeds of $150,550 (the “Units”) each Unit consists of a share and a whole warrant. Each warrant may be exercised for 1 (one) share for 2 (two) years from closing for $0.05. A warrant holder must exercise the Warrant, within 30 days of the shares of the Company trading at a 20 day VWAP of $0.20 or greater once the 4 month statutory hold has expired. The Company paid finders fees of $10,928 and issued 312,229 finders warrants. The warrants have the same terms as above. The proceeds of the financing will be used for exploration work and general administration. In a sperate transaction the Company issued 2,000,000 shares to complete the acquisition of the Topley West Property as announced March 28, 2024. The Company has also issued 100,000 shares at a deemed price of $0.045 to settle outstanding debt with an unrelated party. The securities issued under the financing will be subject to restrictions on resale for 4 (Four) months and a day, pursuant to applicable Canadian securities laws and the rules of the Canadian Securities Exchange. TOPLEY LANDING PROJECT TOPLEY LANDING PROJECT The claims to be explored at Topley Landing are overlapped by Lake Babine Nation (LBN) traditional territory; In consultation with the Lake Babine Nation, Geologica has been granted access to Topley for completion of an IP survey; Geochemistry has identified high priority exploration target areas and kilometer-scale VMS target areas; The region is known for its large porphyry, copper/gold, and copper/molybdenum deposits including the on-trend past-producing Granisle and Bell copper mines; American Eagle Gold Corp. has discovered a copper deposit on trend with Topley; The property is located in central BC, is road accessible and cost effective to explore year round BC Hydro power lines transect the property and several water sources are available on the property; Rail Access to tide water is only 40km away; Porphyries contain the largest reserves of Copper and close to 50% of gold reserves in BC; Topley Property consists of 11 mineral claims totaling 4,216 Ha with six known prospects and showings. About Geologica Resource Corp. Geologica Resource Corp. is a mineral explorer, building shareholder value through the acquisition of projects with significant technical merit. The Company has an option agreement and a purchase agreement for 100% of the mineral claims known as the Topley Project, located in central British Columbia. Further information on Geologica Resource Corp. can be found on the Company’s website https://geologicaresource.com/ and on SEDAR at https://www.sedarplus.ca Doug Unwin President & CEO (604) 762-5355 doug.unwin@geologicaresource.com Forward-Looking Statements This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information is characterized by words such as “plan”, “expect”, “ensuring”, “believe”, “anticipate”, “will”, “would” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward-looking information pertaining to the Company’s plans and objectives with respect to the Topley Project. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, changes in the state of equity and debt markets, fluctuations in commodity prices, delays in obtaining required regulatory or governmental approvals, environmental risks, limitations on insurance coverage, failure to obtain all necessary regulatory approvals, risks and uncertainties inherent in the exploration and development of mineral properties, and other risk factors set forth in the long-form prospectus of the Company dated July 22, 2022 under the heading “Risk Factors”, a copy of which is available on the Company’s SEDAR profile at www.sedarplus.ca. Forward-looking information in this news release is based on the opinions and assumptions of management considered reasonable as of the date hereof, including, but not limited to, the assumption that general business and economic conditions will not change in a materially adverse manner. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information. The Company disclaims any intention or obligation to update or revise any forward-looking information, other than as required by applicable securities laws. Tags: INDUSTRIAL METALS & MINERALS 0 Related News @ the Bell: Resource stocks lift TSX 21 hours ago @ the Bell: How did markets react to the BoC rate cut? 1 day ago @ the Bell: TSX hits one-month low 2 days ago Recent U.S. Press Releases Geologica Closes Financing And Property Acquisition 5 hours ago INDUSTRIAL METALS & MINERALS ADDITION OF NEW COPPER CLAIMS AT TOPLEY PROJECT April 18, 2024 INDUSTRIAL METALS & MINERALS Xcyte Digital Corp. Purchases Assets of A+ Conferencing April 3, 2024 TECHNOLOGY More Press Releases » Featured News Links Flow Test and Laboratory Analysis Confirm a Major New HELIUM Discovery in Minnesota This Small-Cap Gold Stock Keeps Notching Up High-Grade Gold in Nevada Thematic Insights: Free Podcast Exploring Market Trends & Emerging Sectors Get the latest news and updates from Stockhouse on social media facebook twitter linkedin Follow STOCKHOUSE Today (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2347)
•••
Post by nozzpackon Aug 13, 2021 9:15am
150 Views
Post# 33699859

AGM on Aug 19 / 21

AGM on Aug 19 / 21That will have been 16 days after the announced pause for 2 weeks.

So, they will have the two week data by then for disclosure at the AGM.

I have no doubt that the cause of the 3 anomalous LFTs along with  results from previous much higher doses will have been collated for shareholders.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities